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Abstract
Background: Pneumococcal serotyping is usually performed by Quellung reaction, considered the gold standard test.
However the method cannot be used on culture-negative samples. Molecular methods can be a useful alternative. The aim
of the study was to evaluate the use of Multiplex-sequential-PCR (MS-PCR) or Realtime-PCR on blood samples for diagnosis
and serotyping of invasive pneumococcal disease (IPD) in a pediatric clinical setting.
Methodology/Principal Findings: Sensitivity and specificity of MS-PCR and Realtime-PCR have been evaluated both on 46
well characterized pneumococcal isolates and on 67 clinical samples from children with culture-negative IPD. No difference
in sensitivity and specificity between MS-PCR and Realtime PCR was found when the methods were used on isolates: both
methods could type 100% isolates and the results were always consistent with culture-based methods. On the contrary,
when used on clinical samples 43/67 (64.2%) were typeable by MS-PCR and 61/67 (91.0%) by Realtime-PCR (p=0.0004,K
Cohen 0.3, McNemar’s p,0.001). Non-typeability by MS-PCR was associated in 18/20 cases (90.0%) with low bacterial load.
The difference between the two methods was present both when they were used on normally sterile fluids (respectively 31/
33 (93.9%) typeable samples for Realtime-PCR and 24/33 (72.7%) for MS-PCR, p=0.047, 95%CL 0.03–0.98; K Cohen 0.3;
McNemar’s p=0.0016) and when they were used on nasopharyngeal swabs (respectively 30/34 (88.2%) typeable samples
for Realtime-PCR and 19/34 (55.9%) for MS-PCR, p=0.007, 95%CL 0.04–0.66); the presence of multiple pneumococcal
serotypes in nasopharyngeal swabs was found more frequently by Realtime PCR (19/30; 63.3%) than by Multiplex-sequential
PCR (3/19; 15.8%; p=0.003;95%CL 1.87–39.97).
Conclusions/Significance: In conclusion, both MS-PCR and Realtime PCR can be used for pneumococcal serotyping of most
serotypes/serogroups directly on clinical samples from culture-negative patients but Realtime-PCR appears more sensitive.
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Introduction
Streptococcus pneumoniae is considered the leading cause of
invasive bacterial infections both in children and in elderly
people [1]. The organism causes at least 1.6 million deaths each
year and is responsible for several invasive infections [2].
Capsular polysaccharide helps to differentiate Streptococcus pneu-
moniae into 92 distinct serotypes [3]. Effective vaccines induce
specific anti-capsular antibodies [4]. The available vaccine
currently used in pediatric age induces protection against 7
major serotypes and new vaccines against 10 or 13 serotypes will
be available soon. Individuating serotypes causing invasive
infections is extremely important in order to understand
pneumococcal epidemiology, plan correct vaccination programs
and evaluate the impact of the existing program. On the other
hand, molecular typing is an important tool also in studies on
pneumococcal carriage and especially in studies focusing on
serotype replacement occurring spontaneously or as a conse-
quence of immune pressure induced by vaccination.
Pneumococcal serotyping is currently performed by using
capsular swelling (Quellung) reaction, considered the traditional
‘gold standard’ [5–6]. However, cross-reactions between serotypes
canoccurandsomestrainsremainnon-serotypable[7–9].Technical
expertise requirements as well as the need for viable bacteria may be
drawbacks of the culture detection-system. Actually, autolysis in
culture media and antibiotic therapy often performed on an
outpatient basis at the beginning of febrile illness, prevent pathogens
from growing in culture plates so making diagnosis and serotyping
with culture methods more difficult. Molecular methods, based on
DNA detection, do not require viable bacteria so that can be
consideredasusefulhelptoculturalmethodsespeciallyincaseswhen
antimicrobial treatment was already started [10].
As for carriers, studies aimed to evaluate pneumococcal
serotype replacement need to consider the presence of multiple
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typing of pneumococci in nasopharyngeal swabs is usually
obtained by a single colony method [11] on culture plates. On
that way, a single serotype per patient is usually found and
multiple colonization, which is a very frequent condition, cannot
be revealed [12]. Colonization studies in which several colonies
are studied are much more informative, but much more expensive.
In recent years, molecular techniques have been applied
successfully in the identification of infectious agents. The
knowledge of DNA/RNA sequences of most bacteria allows to
obtain etiologic diagnosis [13] and bacterial serotyping even where
standard culture methods fail [10,14–15].
We have previously described that multiplex sequential PCR
(MS-PCR) performed directly on clinical samples (both blood and
other normally sterile fluids) for pneumococcal serotyping has a
sensitivity which is significantly higher than that of culture [14].
However, even though the possibility of pneumococcal serotyping
has been greatly ameliorated by MS-PCR, it could be further
increased by the use of Realtime-PCR known, at present, as one of
the most specific and sensitive molecular method [16–18].
The aim of the present study was to compare sensitivity and
specificity of Realtime-PCR versus MS-PCR for pneumococcal
typing both on isolates and on clinical samples from patients with
culture-negative invasive pneumococcal disease.
Results
Molecular diagnosis of Streptococcus pneumoniae
Isolates. All the pneumococcal isolates (either those obtained
from ATCC or those obtained from the Microbiology Laboratory)
resulted positive with both RT PCR (lytA gene) and MS-PCR
(CpsA gene).
Biological samples. All the samples were positive for lytA
gene. Positivity for both lytA in Realtime-PCR and CpsA in MS-
PCR was found in 67/69 (97.1%) samples (4 CSF, 4 pleural fluids,
25/27 blood samples, 34 pharyngeal swabs). The two samples
(blood) negative in MS-PCR had a Realtime-PCR CT respectively
of 38 and 39. Only the 67 samples positive for both lytA gene in
Realtime-PCR and CpsA gene in MS-PCR were included in the
study for serotyping analysis.
Serotyping of Streptococcus pneumoniae Isolates
All the eight isolates obtained from ATCC could be serotyped
by both molecular methods and the results were consistent with
ATCC serotype.
All the 38 Streptococcus pneumoniae isolates could be serotyped by
both molecular methods and showed a complete concordance with
serologic typing (serotypes 1, 3, 4, 5, 6A: 3 isolates/each; serotypes
6B,7F, 8, 9V, 12F, 14: 2 isolates/each; serotypes 10, 15B/C, 18C,
19A, 19F, 20, 22F, 23F, 33, 35B, 38: 1 isolate/each). No cross-
reaction between serotypes was found for any primer/probe set.
Serotyping of Streptococcus pneumoniae from Biological
Samples
Among the 67 biological samples found positive for Streptococcus
pneumoniae, 43/67 (64.2%) could be serotyped by MS-PCR, while
61/67 (91.0%) (p=0.0004; 95%CL 0.06–0.51), could be sero-
typed by RT-PCR (K Cohen:0.3; McNemars’s p,0.001). All CSF
and pleural fluid samples could be serotyped with both molecular
methods (Figure 1).
Among the 67 samples, 41 were typeable with both methods, 2
were typeable only by MS-PCR, 20 were typeable only by
Realtime-PCR and 4 were not typeable with any method.
Among the 20 samples (7/25 whole blood, 13/34 pharyngeal
swabs) which could be typed only with Realtime-PCR, 18/20 had
aC T (threshold cycle) for lytA gene comprised between 30 and 38
(median 34.5; SD 2.4; with no difference between blood samples
and swabs) so suggesting a low bacterial load, while 2 samples
(pharyngeal swabs) had respectively a CT for lytA of 29 and 24.
Figure 1. Number of typeable or non-typeable samples obtained from patients with culture-negative invasive pneumococcal
infections as evidenced by Multiplex Sequential PCR or Realtime-PCR (sensitivity of Realtime vs Multiplex Sequential PCR
p=0.0004; 95%CL 1.98–17.05).
doi:10.1371/journal.pone.0009282.g001
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only by MS-PCR were respectively serotypes 6C and 11A, primers
of which were not available for RT-PCR at the time of the study.
A statistically significant difference between the two methods
was present both when they were used on normally sterile fluids
(blood, CSF, pleural fluid) or on nasopharyngeal swabs. When
used on normally sterile fluids 24/33 (72.7%) samples were
typeable with MS-PCR and 31/33 (93.9%)with Realtime-PCR
(p=0.047, 95%CL 0.03–0.98; K Cohen 0.3; McNemar’s
p=0.0016); when the two methods were used on nasopharyngeal
swabs 19/34 (55.9%) samples were typeable by MS-PCR and 30/
34 (88.2%) by Realtime-PCR (p=0.007, 95%CL 0.04–0.66).
Multiple serotypes/serogroups of Streptococcus pneumoniae
were demonstrated in 3/19 (15.8%) swabs typed by MS-PCR and
in 19/30 (63.3%) pharyngeal swabs typed by Realtime-PCR
(Figure 2), (p=0.003; 95%CL=1.87–39.97). MS-PCR demon-
strated 2 different serotypes in 3/19 (15.8%), while in 16/19
samples (84.2%) only one serotype was found. Realtime PCR
demonstrated 1 single serotype in 11/30 (36.7%), 2 different
serotypes in 13/30 (43.3%), 3 different serotypes in 5/30 (16.7%)
and 4 different serotypes in 1/30 (3.3%). The mean number of
serotypes found in each nasopharyngeal swab was 1.2 (range 1–2)
for MS-PCR and 1.9 (range 1–4) for Realtime-PCR (p=0.001;
95% CL=0.33–1.11). Multiple serotypes were never found in
blood or CSF or pleural fluid.
Discussion
The present study indicates that Realtime-PCR can be used
directly on clinical samples for Streptococcus pneumoniae serotyping
and has a greater sensitivity than Multiplex sequential PCR in
identifying and serotyping Streptococcus pneumoniae in any body fluid
(blood, cerebrospinal fluid, pleural fluid, nasopharyngeal swabs).
At present, what is known about pneumococcal serotype
distribution in invasive infections or carriage, is mostly based on
cultural isolate typing [19]. Pneumococcal serogroup and serotype
identification is performed by using large panels of expensive
antisera by capsular swelling reaction [5,6,8]. However cross-
reactions between serotypes can occur and some strains are
difficult to serotype or even remain non-serotypable [7–9].
Molecular serotyping of isolates [20] adds specificity to the test
but cannot be performed on culture-negative samples. Actually, it
is well known that culture may often give false-negative results
because of small sample volume, previous antibiotic therapy [10],
or unsatisfactory conditions of sample transport and storage which
can impair the viability of pathogens. In all the cases where culture
growth is not obtained, also serotyping cannot be performed
neither with Quellung reaction nor with molecular methods
applied on isolates.
We previously demonstrated, in accord with Corless et al. [13]
that Realtime PCR is more sensitive than culture or end-point
PCR for diagnosis of pneumococcal infection [14]. As for
serotyping we previously demonstrated that MS-PCR can be
used directly on whole blood samples for Streptococcus pneumoniae
serotyping so giving results where cultural methods fail [14].
Similar results have been obtained on cerebrospinal fluid, on
culture-negative meningitis in children [15].
However, even though more sensitive than cultural methods,
MS-PCR leaves a not-negligible percentage of cases as non-
typeable. The comparison between the present data and data
obtained in previous researches [14,15] demonstrates that the
percentage of cases which remained non-typeable with MS-PCR is
low or null when cerebrospinal fluids or pleural fluids are used, but
it significantly increases if other biological samples, such as blood
or nasopharyngeal swabs are used (fig. 1).
Among molecular methods Realtime-PCR has probably the
best performance in terms of sensitivity, specificity and rapidity
[16], so that it has being used for more than 10 years over a large
spectrum of fields in biological research [17,21,22]. The present
study demonstrates that no difference in sensitivity exists between
the two tests when used on isolates. On the contrary, when used on
clinical samples from culture-negative invasive pneumococcal
infection, Realtime-PCR appears significantly more sensitive than
MS-PCR irrespective of the sample used: multiplex sequential
Figure 2. Presence of single or multiple pneumococcal serogroups/serotypes in nasopharyngeal swabs as evidenced by Multiplex
Sequential PCR or Realtime-PCR (frequency of multiple serotypes/serogroup evaluated with Realtime PCR vs Multiple Sequential
PCR p=0.003; 95%CL=1.87–39.97).
doi:10.1371/journal.pone.0009282.g002
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samples while Realtime-PCR allowed pneumococcal serotyping
in over 90% samples using a panel of 21 primer/probe sets, with
good concordance between the two tests. The lower sensitivity of
MS-PCR compared with Realtime-PCR is particularly evident in
samples with low bacterial load, as often happens in whole blood
of patients with pneumonia.
As for nasopharyngeal swabs, both Realtime-PCR and MS-
PCR evidenced the presence of multiple serogroups/serotypes of
Streptococcus pneumoniae. However Realtime-PCR appears signifi-
cantly more sensitive than MS-PCR. The data have been obtained
in a population of severely ill children in whom an invasive
bacterial infection was suspected. Therefore the presence of
multiple serotypes/serogroups may not reflect the situation of
healthy children and cannot be considered as a co-colonization.
The evaluation of multiple colonization has important implica-
tions in the study of pneumococcal carriage and serotype
replacement. At present in carriage studies the single colony
method is commonly used to determine the serotype by the
Quellung reaction. When colonies of multiple morphologies are
present, selection by morphology adds some information, but
nevertheless both methods underestimate the true rate of multiple
carriage [14,15,23–25]. Actually, based on the single-colony
cultural method, a single serotype per patient can be found and
multiple colonization, which is a frequent condition cannot be
revealed [24,25]. Colonization studies in which several colonies
are studied give more complete information but are limited by the
high cost. In order to draw conclusions on limited phenomena as
initial serotype replacement, individuating multiple colonization
will be mandatory in future studies and molecular methods could
be an important tool.
The MS-PCR method used in the present study, using 31
primer couples, was able to identify 31 serogroups/serotypes. The
panel for Realtime PCR included primers/probes for 21
serogroup/serotype. The difference is in favour of MS-PCR
sensitivity (and therefore it obviously goes toward the null
hypothesis of the study which was aimed to demonstrate the
higher sensitivity of Realtime PCR in serotyping directly from
clinical samples) and nonetheless the higher sensitivity of Realtime
PCR has been demonstrated. Actually, the 10 serogroup/
serotypes not included in the Realtime PCR panel were expected
to be responsible, according to pneumococcal epidemiology of
European countries of less than 10% cases.
Potentially other primer/probe sets could have been used in the
present study and a further decrease in the rate of non-typeable
pneumococcal infection could be achieved. However even though
Realtime-PCR and MS-PCR are undoubtedly less expensive than
serological methods (respectively 1:1.4 and 1:2.3 for Realtime-
PCR or MS-PCR vs serologic methods for 21 serotypes) (data not
shown), the cost of the assay can be kept down accepting a small
percentage of non-typeable samples similarly to what routinely
occurs with serological methods. Actually, seen the epidemiolog-
ical distribution of pneumococcal serotypes in Europe and USA
[26–28], a further increase in the rate of typeable samples of only
5% would probably have required a disproportionate effort.
RT-PCR is a very sensitive methods and can help in diagnosis
and serotyping of IPD. However, when a positive result is obtained
in samples considered negative by the established ‘gold standard’
(culture), it might be speculated that this is due to poor specificity
of PCR rather than improved sensitivity. Actually, in the past
years, PCR was found positive in blood samples from healthy
controls [29,30]. However, the new techniques used in the present
paper (Realtime PCR instead of end-point PCR) and the use of
different target genes (lytA instead of ply) seem to eliminate the
problem of false positive results described in the past. Moreover, in
the present study, the diagnosis of pneumococcal infection done
with the mosts specific [18] lytA gene was confirmed in MS-PCR
by amplification of cps gene. Moreover, more than 90% of the
samples could also be serotyped by Realtime PCR, using specific
primers for each serotype, different from those for cps and lytA.
Positive results from all these different targets in the same sample
enhance confidence in the sample positivity.
The flexibility of the Realtime-PCR is useful to make the
method suitable in clinical settings in different geographical areas
[31]; actually primer/probe panel can be modified including
primer/probe specific for serotypes which are present in a
geographical area. Serotype 2, which has a negligible frequency
in western countries, is prevalent in south-east Asia. As a
consequence, primer/probes for serotype 2 could be designed
and included in a Realtime panel more suitable for Asian countries
[32]. Moreover distribution of pneumococcal serotypes may
change over years, both as a consequence of immune pressure
[33] and of secular trend [34,35]. Therefore when the percentage
of non-typeable samples increases new primer/probe sets targeting
different serotypes can be added or substituted to the routinely
used sets so maintaining a limited panel with affordable costs. This
is important in any country and particularly useful in low-income
countries, in which culture-based serotyping is barely affordable
for the high costs and culture-negative cases have the highest rates
[15].
The RT-PCR method for detecting bacterial infections due to
Streptococcus pneumoniae, is simple, rapid, and more sensitive then
previously used methods. The use of lytA gene (known to be
extremely sensitive and specific) [18] in RT-PCR and CpsA gene in
MS-PCR enhanced, in the study, confidence in sample positivity.
Other methods have been proposed for pneumococcal typing
by molecular methods [36] but the presence of degenerate primers
may reduced test sensitivity and the results may be difficult to
interpret. As far as we could evaluate from the literature, the
method presented in our study describes the largest panel of
specific primer/probe sets for pneumococcal serotyping by
Realtime-PCR and does not include any degenerate primer so
to increase test specificity. Adjunctive tests can be useful to
differentiate closely related serotypes [37] and serologic serotyping
remains a useful tool [38].
In conclusion, both MS-PCR and Realtime-PCR appears have
be able to obtain pneumococcal typing from isolates. Realtime-
PCR is significantly more sensitive than MS-PCR in pneumococ-
cal serogrouping/serotyping from clinical samples obtained from
culture-negative invasive infections and in individuating presence
of multiple pneumococci in nasopharyngeal swabs.
Distinction between different serotypes within the same
serogroup may be necessary when, as in the case of 19F and
19A no cross-protection is induced between the two serotypes [39].
In other cases serotyping may be less important because vaccine-
induced cross-protection between different serotypes within the
same serogroup is known [39]. For this reason in the present work
different specific primers for 19A or 19F have been included while
serotypes 6A and 6B or serotypes within the group 18 were not
distincted even though molecular techniques are available in our
laboratory (data not shown). Based on those consideration a
limited panel of 21 primer/probe sets has been designed with the
aim to maintain an effective balance between expenses and
epidemiological information. Actually, using a panel of 21
primers/probes, Realtime-PCR allows to achieve, today, pneu-
mococcal serogrouping/serotyping in over 90% cases of culture-
negative invasive pneumococcal disease in Italy and in most
western countries where the serotype epidemiology is similar.
Pneumococcal Typing by RT-PCR
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Written informed consent was obtained from all parents or
guardians; the study has been approved by the institutional review
board of the Department of Pediatrics, Anna Meyer Children’s
Hospital and University of Florence, ITALY.
Bacterial DNA Extraction
Bacterial genomic DNA was extracted from bacterial strains or
biological samples using QIAmp DNeasy Blood & Tissue kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
instructions for extraction of a 200 mL sample.
Molecular Diagnosis of Streptococcus pneumoniae
Infection
The presence of Streptococcus pneumoniae DNA in biological
samples and isolates was evaluated by molecular methods as
previously described [14]. Primers and probes within the
previously published autolysin gene lytA [14,18] were used for
RT amplification at a final concentration of 400 nM for primers,
and 400 nM for JOE-labeled probes. The cycle threshold (CT)
value is the PCR cycle number (out of 45) at which the measured
fluorescent signal exceeds a calculated background threshold
identifying amplification of the target sequence. If no increase in
fluorescent signal is observed after 45 cycles, the sample is assumed
to be negative. The presence of Streptococcus pneumoniae DNA was
confirmed by the amplification of CpsA gene in multiplex
sequential PCR as previously reported [10,14] and briefly
described in the next paragraph. Only samples positive for both
lytA gene in RT-PCR and CpsA in MS-PCR were included in
serotyping analysis.
Streptococcus pneumoniae Isolates
Eight bacterial strains of Streptococcus pneumoniae were obtained
from ATCC (respectively ATCC 6301 for 1, ATCC 6304 for 4,
ATCC 6305 for 5, ATCC 10357 for 19A, ATCC 6323 for 23F,
ATCC 6326 for 6B, ATCC 10368 for 9V, ATCC BAA-659 for
6A); 38 well characterized Streptococcus pneumoniae isolates from
twenty-one serotypes (1, 3, 4, 5, 6, 7F, 8, 9V,10, 12F, 14, 15B/C,
18C, 19A, 19F, 20, 22F, 23F,33, 35B, 38) which had been isolated
from blood and/or CSF and/or throat swab samples of patients
and stored in germ bank at the Microbiology Laboratory of the
Anna Meyer Children’s University Hospital were used for
molecular serotyping.
Biological Samples
Sixty-nine biological samples (27 blood samples, 4 cerebrospinal
fluid (CSF) samples, 4 pleural fluids ands 34 pharyngeal swabs),
found positive for Streptococcus pneumoniae by Realtime-PCR with
primer/probes from the lytA gene, as previously described [14],
and obtained from children with culture-negative invasive
pneumococcal infection were included in serotyping analyses both
by multiplex-sequential PCR (MS-PCR) and Realtime-PCR.
Case Definition
A patient with culture-negative invasive pneumococcal infection
was defined as a patient in whom clinical signs of bacterial
infections were associated with Realtime-PCR positivity for lytA
gene (14) and negativity of cultural tests.
Serotyping of Isolates and Clinical Samples
To prove sensitivity of the tests, both multiplex sequential PCR
and Realtime-PCR were preliminarly performed on isolates.Then
both methods were used directly on clinical samples from patients
with a clinical suspicion of invasive bacterial infection. All the
samples which had resulted positive with Realtime-PCR for lytA
gene were included in serotyping analysis.
PCR serotyping by Multiplex sequential PCR. Briefly,
thirty-one primer couples [14,20,37,38] were grouped into nine
multiplex reactions. CpsA (pneumococcal capsular polysaccharide
synthesis gene) primers were included in all the reaction mix as a
confirmatory test [14,20,37]. Amplification was performed in a
Perkin-Elmer GeneAmp PCR system 2720 (Applied Biosystems,
Foster City, CA, USA) under the following conditions: 95uC for 15
minutes followed by 35 amplification cycles of 94uC for 30
seconds, 54uC for 90 seconds, and 72uC for 60 seconds. A final
hold was performed at 72uC for 10 minutes. The PCR products
were analyzed by gel electrophoresis on 2% NuSieve agarose gels
(Cambrex Bio Science, Inc., Rockland, ME) in 1x TAE buffer.
The sizes of the PCR products were determined by comparison
with the molecular size standard (100-bp ladder; Novagen, Inc.).
Samples negative with both CpsA primers and primers specific
for all serotypes were excluded from the study. If amplification of
CpsA was present but no other PCR product could be determined,
the sample was reported as non-typeable.
PCR serotyping by Realtime PCR. Primers and probes
were designed using the ABI Primer Express Software Package
based on previously published CpsA gene (Table 1). Primer/probe
sets for Realtime PCR and MS-PCR were obtained from the same
gene region. The primer/probe panel was chosen on the basis of
pneumococcal epidemiology in European countries, with the aim
to include serotypes/serogroups causing over 90% cases of
invasive pneumococcal disease.
The RT amplification was performed in 25 mL reaction
volumes containing 2x TaqMan Universal Master Mix (Applied
Biosystem, Foster City, CA, USA); primers and JOE labeled
probes were used at a concentration of 400 nM; FAM labeled
probes at a concentration of 200 nM. Six ml of DNA extract was
used for each reaction. All reactions were performed in triplicate.
A negative control (both blood samples from healthy controls and
sterile water samples) and a positive control (blood samples or
cerebrospinal fluid samples known to be positive for Streptococcus
pneumoniae both by cultural and molecular methods) were
included in every run. DNA was amplified in an ABI 7500
sequence detection system (Applied Biosystem, Foster City, CA,
USA) using, for all the primers couples, the same cycling
parameters as follows: 50u for 2 min for UNG digestion, 95uC
for 10 min followed by 45 cycles of a two-stage temperature profile
of 95uC for 15 sec and 60uC for 1 min.
If no increase in fluorescent signal was observed after 45 cycles
for any of the primer/probe set, the sample was assumed to be
negative with the serotype specific primers and was reported as
non-typeable.
Statistical Analysis
Data were evaluated to determine how many samples were
positive by each test (MS-PCR or Realtime PCR), as well as those
positive by two tests and those positive by only one test. Agreement
between the two tests was assessed by Cohen’s kappa statistic, with
values of 0.00 to 0.20 indicating poor agreement, 0.21 to 0.40
indicating fair agreement, 0.41 to 0.60 indicating moderate
agreement, 0.61 to 0.80 indicating good agreement, and 0.81 to
1.00 indicating excellent agreement. Marginal homogeneity of the
two tests was assessed by McNemar’s test. Results were expressed
as mean levels and standard deviations. All continuous variables
were expressed as mean 6 SD. Fisher exact test and Pearson’s chi-
square test were used when appropriate.
Pneumococcal Typing by RT-PCR
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An External Quality Control for Real-time PCR and standard
PCR is regularly carried out with excellent results in our
Laboratory of Immunology where all the molecular test were
performed.
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